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Table 1 – Characteristics of HIV-positive mothers of
infants infected by vertical transmission, Campo
Grande, Brazil.
Mother’s characteristics Total
n = 99 patients
Mother’s age at labor, n (%)
≤17 years old 12 (13.1)
≥18 and ≤24 years old 34 (37.4)
≥25 and ≤34 years old 41 (45.0)
≥35 years old 4 (4.4)
Unknown 8
Maternal exposure, n (%)
Sexual 81 (81.8)
Sexual and intravenous drug use 18 (19.2)
Pregnant HIV diagnosis, n (%)
Before pregnancy 53 (53.5)
During pregnancy or labor 13 (13.1)
Postpartum 33 (33.3)
Pre-natal, n (%)
Yes 64 (66.6)
No 32 (33.3)
Unknown 3
Delivery, n (%)
Vaginal birth 57 (60.6)
Cesarean section 37 (39.4)
Unknown 5
Breastfeeding, n (%)
Yes 75 (82.4)
No 16 (17.6)
Unknown 8HIV infection
Dear Editor,
The increment of HIV transmission involving the female pop-
ulation of childbearing age favors HIV vertical transmission.1
Programs for the prevention of mother-to-child-transmission
(PMTCT) of HIV are part of the solution to eliminate new pedi-
atric HIV infections and that can reduce the risk of MTCT to
fewer than 2%.2
Herein we  report missed opportunities for preventing peri-
natal HIV infection abstracted from medical records of a
cohort of patients. Vertically HIV-infected infants followed up
from birth or from the time of diagnosis receiving care at
the referral services of Campo Grande city, in Midwest Brazil,
between 1993 and 2014 were included. Patients who died dur-
ing the study period were excluded from the analysis due to
insufﬁcient information in the medical records.
One hundred forty-one patients were identiﬁed until 2014,
99 were eligible for inclusion and 42 died during the study
period. Most of the children were diagnosed owing to their
parents’ HIV diagnoses (p < 0.001), including one patient diag-
nosed at 127 months old. One teenager was diagnosed at 144
months because of the death his older brother.
Seventy-six mothers (96.2%) had not received ARV pro-
phylaxis during pregnancy, while 74 (92.5%) had not used
prophylaxis during labor, including two women who had
received ARVT during pregnancy. Moreover, 91 (91.9%) chil-
dren had not received prophylaxis ARV. Although 66.0% of HIV
infections in the women had been diagnosed before delivery
(Table 1), 82.4% of the newborns were breastfed. Despite lack
of ARV prophylaxis, most of the patients (52.5%) were between
16 and 24 years old in 2014.
Since 1997, voluntary prenatal HIV testing ought to be
offered in Brazil. The fact that 43% of the children in this
cohort were born before 1997 contributed to the majority of
pregnant women having been diagnosed after delivery. On
the other hand, 57% of the children were born after 1997 and
their HIV-infected mothers could have been diagnosed during
pregnancy.Furthermore, women who were receiving ARVT during
pregnancy and did not use prophylaxis during labor, as well
as women who  were aware of their HIV status before preg-
nancy and had not undergone Cesarean delivery raises theDuration of breastfeeding (mean in months) 11.68
issue of communication among HIV care services, antenatal
care, maternity services, and the involved woman. Pregnant
HIV diagnosis occurred before pregnancy in more  than half
of the patients and even though the Brazilian Guidelines for
Prevention of HIV Transmission were not applied.
Regarding breastfeeding, in settings such as sub-Saharan
Africa, where HIV-infected mothers must decide between the
reduction of HIV transmission and the risk of death,3 their
choice to breastfeed is understandable. In Brazil, since 2002,
formula has been provided for infants born to HIV-infected
mothers.
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In conclusion, the recommendations from the Brazilian
ational STD/AIDS Program of the Ministry of Health for the
eduction of HIV vertical transmission are not being correctly
pplied; there is lack of integration among health services, and
ffective biomedical interventions seem not be effective with-
ut concomitant interventions on the social environment.
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